APOC1 and hypertriglyceridemia: Inhibition of the apoE-mediated hepatic uptake of VLDL is not the sole mechanism accounting for the hypertriglyceridemic effect of apoC1 overexpression since apoC1 transgenic mice also develop hypertriglyceridemia in an apoE-deficient context [8, 67].